secwatch.observer — SEC 8-K summary
======================================

Issuer:     CODEXIS, INC. (CDXS)
CIK:        0001200375
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0001193125-25-007775
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Codexis appoints Christos Richards to Board of Directors
--------------------------------------------------------

- Appointment effective January 14, 2025 as Class II director with term until 2027 annual meeting.
- Richards is independent under Nasdaq rules; will serve on Nominating and Governance and Strategy Committees.
- Annual cash retainer of $50,000 plus $10,000 each for committee service; initial RSU grant of $200,000 vesting over three years.
- Richards brings executive search and biopharma board experience, previously on Coherus BioSciences board.
- No arrangements or transactions with the company other than standard director compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1200375/000119312525007775/0001193125-25-007775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1200375/000119312525007775/d876172d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-007775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer